Ayrfa Newclei completes tens of millions of yuan in Series A2 financing.

On February 14th, Aelfa Newclai Medical Technology Co., Ltd. announced the completion of tens of millions of yuan in Series A2 financing, with participation from Yuanchuang Duoying Investment Group, Chongqing Shizhu He You Ke Chuang Fund, Shijiazhuang Qihang Talent Fund under Haichuanghuichuangtou, and Shijiazhuang Yanhai Fund. This round of financing will be used to further promote the company's production capacity deployment in the field of isotope production, accelerate the collaborative construction of its two major production bases in North China and East China, and enhance the market supply capacity of key alpha isotopes such as Aelfa-211.